Literature DB >> 31243882

Difference in 24-hour urine sodium excretion between controlled and uncontrolled patients on antihypertensive drug treatment.

Moo-Yong Rhee1, Sang-Ho Jo2, Ji-Hyun Kim1, Kwang-Il Kim3, Deuk-Young Nah4, Sun-Woong Kim5, Namyi Gu6, Ki-Chul Sung7, Kyung-Soon Hong8, Eun-Joo Cho9, Sim-Yeol Lee10.   

Abstract

The objective of this study was to evaluate the association between sodium intake and blood pressure (BP) control in hypertensive patients taking antihypertensive medications by using 24-hour urine collection and 24-hour ambulatory BP. This is a cross-sectional community-based study and conducted in 2011 and 2012. A total of 1128 participants were recruited from five cities in Korea. Among them, 740 participants who had complete 24-hour urine collection and valid 24-hour ambulatory BP data were included in this study. Participants were divided into four groups: normotensives (NT, n = 441), untreated hypertensive patients (UTHT, n = 174), controlled hypertensive patients (CHT, n = 62), and uncontrolled hypertensive patients (UCHT, n = 63). UCHT and CHT groups showed higher mean age than NT and UTHT groups. UCHT and UTHT groups showed higher 24-hour systolic BP (SBP) and diastolic BP (DBP) than NT and CHT groups. UCHT group had the highest level of 24-hour urine sodium. Multivariate analysis adjusted with age, gender, body mass index, estimated glomerular filtration rate, and use of diuretics showed higher level of 24-hour urine sodium in UCHT group than that in CHT group. Multivariate logistic regression analysis revealed independent association of the amount of 24-hour urine sodium with uncontrolled BP in hypertensive patients on antihypertensive drug treatment. Higher level of 24-hour urine sodium excretion in uncontrolled hypertensive patients suggests that excessive sodium intake could be associated with blunted BP lowering efficacy of antihypertensive medications. ©2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  antihypertensive drugs; hypertension; sodium

Mesh:

Substances:

Year:  2019        PMID: 31243882      PMCID: PMC8030394          DOI: 10.1111/jch.13610

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

2.  Modulation by dietary salt of verapamil disposition in humans.

Authors:  D Darbar; M F Fromm; S Dell'Orto; R B Kim; H K Kroemer; M Eichelbaum; D M Roden
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

3.  Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.

Authors:  M R Weir; S G Chrysant; D A McCarron; M Canossa-Terris; J D Cohen; P A Gunter; A J Lewin; R F Mennella; L W Kirkegaard; J H Hamilton; M H Weinberger; A B Weder
Journal:  Hypertension       Date:  1998-05       Impact factor: 10.190

4.  Validation of the mobil-O-Graph: 24 h-blood pressure measurement device.

Authors:  Wolfgang Wei; Markus Tölle; Walter Zidek; Markus van der Giet
Journal:  Blood Press Monit       Date:  2010-08       Impact factor: 1.444

Review 5.  Compliance to a low-salt diet.

Authors:  F C Luft; C D Morris; M H Weinberger
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

6.  A validation study on food composition tables for the international cooperative INTERMAP study in Japan.

Authors:  Katsushi Yoshita; Katsuyuki Miura; Akira Okayama; Nagako Okuda; Sally F Schakel; Barbara Dennis; Shigeyuki Saitoh; Kiyomi Sakata; Hideaki Nakagawa; Jeremiah Stamler; Hirotsugu Ueshima
Journal:  Environ Health Prev Med       Date:  2005-05       Impact factor: 3.674

7.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

8.  Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers.

Authors:  Michel Azizi; Anne Blanchard; Beny Charbit; Grégoire Wuerzner; Séverine Peyrard; Eric Ezan; Christian Funck-Brentano; Joël Ménard
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

9.  Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake.

Authors:  F C Luft; N S Fineberg; R S Sloan
Journal:  Hypertension       Date:  1982 Nov-Dec       Impact factor: 10.190

10.  A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection.

Authors:  J T Knuiman; J G Hautvast; L van der Heyden; J Geboers; J V Joossens; H Tornqvist; B Isaksson; P Pietinen; J Tuomilehto; L Poulsen
Journal:  Hum Nutr Clin Nutr       Date:  1986-05
View more
  4 in total

1.  Dietary Sodium Intake and Health Indicators: A Systematic Review of Published Literature between January 2015 and December 2019.

Authors:  Katherine J Overwyk; Zerleen S Quader; Joyce Maalouf; Marlana Bates; Jacqui Webster; Mary G George; Robert K Merritt; Mary E Cogswell
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

2.  Sodium Intake Reduction in Real World.

Authors:  Moo Yong Rhee
Journal:  Korean Circ J       Date:  2020-02-26       Impact factor: 3.243

3.  Difference in 24-hour urine sodium excretion between controlled and uncontrolled patients on antihypertensive drug treatment.

Authors:  Moo-Yong Rhee; Sang-Ho Jo; Ji-Hyun Kim; Kwang-Il Kim; Deuk-Young Nah; Sun-Woong Kim; Namyi Gu; Ki-Chul Sung; Kyung-Soon Hong; Eun-Joo Cho; Sim-Yeol Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-27       Impact factor: 3.738

4.  Further evidence that methods based on spot urine samples should not be used to examine sodium-disease relationships from the Science of Salt: A regularly updated systematic review of salt and health outcomes (November 2018 to August 2019).

Authors:  Kristina S Petersen; Daniela Malta; Sarah Rae; Sarah Dash; Jacqui Webster; Rachael McLean; Sudhir Raj Thout; Norm R C Campbell; JoAnne Arcand
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-10       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.